Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients

Detalhes bibliográficos
Autor(a) principal: Penna, Gerson Oliveira
Data de Publicação: 2017
Outros Autores: Bührer-Sékula, Samira, Kerr, Lígia Regina Sansigolo, Stefani, Mariane Martins de Araújo, Rodrigues, Laura Cunha, Araújo, Marcelo Grossi de, Ramos, Andrea Machado Coelho, Andrade, Ana Regina Coelho de, Costa, Maurício Barcelos, Rosa, Patricia Sammarco, Gonçalves, Heitor de Sá, Cruz, Rossilene, Barreto, Maurício Lima, Pontes, Maria Araci de Andrade, Penna, Maria Lúcia Fernandes
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/25529
Resumo: U-MDT Leprosy clinical trial ± Brazil was funded by the Department of Science and Technology (DECIT) of Brazilian Ministry of Health and the Brazilian Council for Research (CNPq process #403293/2005-7)
id CRUZ_ff6e543481b906bfd5998f55e07ee6ab
oai_identifier_str oai:www.arca.fiocruz.br:icict/25529
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Penna, Gerson OliveiraBührer-Sékula, SamiraKerr, Lígia Regina SansigoloStefani, Mariane Martins de AraújoRodrigues, Laura CunhaAraújo, Marcelo Grossi deRamos, Andrea Machado CoelhoAndrade, Ana Regina Coelho deCosta, Maurício BarcelosRosa, Patricia SammarcoGonçalves, Heitor de SáCruz, RossileneBarreto, Maurício LimaPontes, Maria Araci de AndradePenna, Maria Lúcia Fernandes2018-03-27T17:01:58Z2018-03-27T17:01:58Z2017PENNA, G. O. et al. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients. PLoS Neglected Tropical Diseases, v. 11, n. 7, p. e0005725, 2017.1935-2727https://www.arca.fiocruz.br/handle/icict/2552910.1371/journal.pntd.0005725U-MDT Leprosy clinical trial ± Brazil was funded by the Department of Science and Technology (DECIT) of Brazilian Ministry of Health and the Brazilian Council for Research (CNPq process #403293/2005-7)University of Brasília. Tropical Medicine Centre. Brasília, DF, Brazil / Fundação Oswaldo Cruz. Brasília, DF, BrasilFederal University of Goiás. Tropical Pathology and Public Health Institute. Goiânia, GO, BrazilFederal University of Ceará. Department of Public Health. Fortaleza, CE, BrazilFederal University of Goiás. Tropical Pathology and Public Health Institute. Goiânia, GO, BrazilLondon School of Hygiene and Tropical Medicine. Department of Infectious and Tropical Diseases.London EnglandFederal University of Minas Gerais. Clinical Hospital. Dermatology Department. Belo Horizonte, MG, BraziFederal University of Minas Gerais. Clinical Hospital. Dermatology Department. Belo Horizonte, MG, BraziFederal University of Minas Gerais. Clinical Hospital. Dermatology Department. Belo Horizonte, MG, BraziFederal University of Goiás. Medicine Faculty. Goiania, GO, BrazilLauro de Souza Lima Institute, Bauru, SP, BrazilDona Libania Dermatology Centre. Fortaleza, CE, BrazilTropical Dermatology and Venerology Alfredo da Matta Foundation. Manaus, AM, BrazilFundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, BrasilDona Libania Dermatology Centre. Fortaleza, CE, BrazilFederal University Fluminense. Epidemiology and Biostatistics Department. Niteroi, RJ, BrazilLeprosy control is based on early diagnosis and multidrug therapy. For treatment purposes, leprosy patients can be classified as paucibacillary (PB) or multibacillary (MB), according to the number of skin lesions. Studies regarding a uniform treatment regimen (U-MDT) for all leprosy patients have been encouraged by the WHO, rendering disease classification unnecessary.engPublic Library of ScienceHanseníase MultibacilarFatores de TempoDiagnóstico precoceTuberculose resistente a drogasResultado do tratamentoHumanosBrasilLeprosy, MultibacillaryTime FactorsEarly diagnosisDrug Resistant TuberculosisTreatment OutcomeHumansBrazilUniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patientsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/25529/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALPenna GO Uniform multidrug therapy for leprosy....pdfPenna GO Uniform multidrug therapy for leprosy....pdfapplication/pdf4808381https://www.arca.fiocruz.br/bitstream/icict/25529/2/Penna%20GO%20Uniform%20multidrug%20therapy%20for%20leprosy....pdf2a0d3c844f1146b106bd3c2c66d2fd68MD52TEXTPenna GO Uniform multidrug therapy for leprosy....pdf.txtPenna GO Uniform multidrug therapy for leprosy....pdf.txtExtracted texttext/plain53225https://www.arca.fiocruz.br/bitstream/icict/25529/3/Penna%20GO%20Uniform%20multidrug%20therapy%20for%20leprosy....pdf.txt3a8ca3cf84ba1bab122c82cef49374c2MD53icict/255292023-03-15 14:33:56.99oai:www.arca.fiocruz.br:icict/25529Q0VTU8ODTyBOw4NPIEVYQ0xVU0lWQSBERSBESVJFSVRPUyBBVVRPUkFJUwoKQW8gYWNlaXRhciBvcyBURVJNT1MgZSBDT05EScOHw5VFUyBkZXN0YSBDRVNTw4NPLCBvIEFVVE9SIGUvb3UgVElUVUxBUiBkZSBkaXJlaXRvcwphdXRvcmFpcyBzb2JyZSBhIE9CUkEgZGUgcXVlIHRyYXRhIGVzdGUgZG9jdW1lbnRvOgoKKDEpIENFREUgZSBUUkFOU0ZFUkUsIHRvdGFsIGUgZ3JhdHVpdGFtZW50ZSwgw6AgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaLCBlbQpjYXLDoXRlciBwZXJtYW5lbnRlLCBpcnJldm9nw6F2ZWwgZSBOw4NPIEVYQ0xVU0lWTywgdG9kb3Mgb3MgZGlyZWl0b3MgcGF0cmltb25pYWlzIE7Dg08KQ09NRVJDSUFJUyBkZSB1dGlsaXphw6fDo28gZGEgT0JSQSBhcnTDrXN0aWNhIGUvb3UgY2llbnTDrWZpY2EgaW5kaWNhZGEgYWNpbWEsIGluY2x1c2l2ZSBvcyBkaXJlaXRvcwpkZSB2b3ogZSBpbWFnZW0gdmluY3VsYWRvcyDDoCBPQlJBLCBkdXJhbnRlIHRvZG8gbyBwcmF6byBkZSBkdXJhw6fDo28gZG9zIGRpcmVpdG9zIGF1dG9yYWlzLCBlbQpxdWFscXVlciBpZGlvbWEgZSBlbSB0b2RvcyBvcyBwYcOtc2VzOwoKKDIpIEFDRUlUQSBxdWUgYSBjZXNzw6NvIHRvdGFsIG7Do28gZXhjbHVzaXZhLCBwZXJtYW5lbnRlIGUgaXJyZXZvZ8OhdmVsIGRvcyBkaXJlaXRvcyBhdXRvcmFpcwpwYXRyaW1vbmlhaXMgbsOjbyBjb21lcmNpYWlzIGRlIHV0aWxpemHDp8OjbyBkZSBxdWUgdHJhdGEgZXN0ZSBkb2N1bWVudG8gaW5jbHVpLCBleGVtcGxpZmljYXRpdmFtZW50ZSwKb3MgZGlyZWl0b3MgZGUgZGlzcG9uaWJpbGl6YcOnw6NvIGUgY29tdW5pY2HDp8OjbyBww7pibGljYSBkYSBPQlJBLCBlbSBxdWFscXVlciBtZWlvIG91IHZlw61jdWxvLAppbmNsdXNpdmUgZW0gUmVwb3NpdMOzcmlvcyBEaWdpdGFpcywgYmVtIGNvbW8gb3MgZGlyZWl0b3MgZGUgcmVwcm9kdcOnw6NvLCBleGliacOnw6NvLCBleGVjdcOnw6NvLApkZWNsYW1hw6fDo28sIHJlY2l0YcOnw6NvLCBleHBvc2nDp8OjbywgYXJxdWl2YW1lbnRvLCBpbmNsdXPDo28gZW0gYmFuY28gZGUgZGFkb3MsIHByZXNlcnZhw6fDo28sIGRpZnVzw6NvLApkaXN0cmlidWnDp8OjbywgZGl2dWxnYcOnw6NvLCBlbXByw6lzdGltbywgdHJhZHXDp8OjbywgZHVibGFnZW0sIGxlZ2VuZGFnZW0sIGluY2x1c8OjbyBlbSBub3ZhcyBvYnJhcyBvdQpjb2xldMOibmVhcywgcmV1dGlsaXphw6fDo28sIGVkacOnw6NvLCBwcm9kdcOnw6NvIGRlIG1hdGVyaWFsIGRpZMOhdGljbyBlIGN1cnNvcyBvdSBxdWFscXVlciBmb3JtYSBkZQp1dGlsaXphw6fDo28gbsOjbyBjb21lcmNpYWw7CgooMykgUkVDT05IRUNFIHF1ZSBhIGNlc3PDo28gYXF1aSBlc3BlY2lmaWNhZGEgY29uY2VkZSDDoCBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPCkNSVVogbyBkaXJlaXRvIGRlIGF1dG9yaXphciBxdWFscXVlciBwZXNzb2Eg4oCTIGbDrXNpY2Egb3UganVyw61kaWNhLCBww7pibGljYSBvdSBwcml2YWRhLCBuYWNpb25hbCBvdQplc3RyYW5nZWlyYSDigJMgYSBhY2Vzc2FyIGUgdXRpbGl6YXIgYW1wbGFtZW50ZSBhIE9CUkEsIHNlbSBleGNsdXNpdmlkYWRlLCBwYXJhIHF1YWlzcXVlcgpmaW5hbGlkYWRlcyBuw6NvIGNvbWVyY2lhaXM7CgooNCkgREVDTEFSQSBxdWUgYSBvYnJhIMOpIGNyaWHDp8OjbyBvcmlnaW5hbCBlIHF1ZSDDqSBvIHRpdHVsYXIgZG9zIGRpcmVpdG9zIGFxdWkgY2VkaWRvcyBlIGF1dG9yaXphZG9zLApyZXNwb25zYWJpbGl6YW5kby1zZSBpbnRlZ3JhbG1lbnRlIHBlbG8gY29udGXDumRvIGUgb3V0cm9zIGVsZW1lbnRvcyBxdWUgZmF6ZW0gcGFydGUgZGEgT0JSQSwKaW5jbHVzaXZlIG9zIGRpcmVpdG9zIGRlIHZveiBlIGltYWdlbSB2aW5jdWxhZG9zIMOgIE9CUkEsIG9icmlnYW5kby1zZSBhIGluZGVuaXphciB0ZXJjZWlyb3MgcG9yCmRhbm9zLCBiZW0gY29tbyBpbmRlbml6YXIgZSByZXNzYXJjaXIgYSBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPIENSVVogZGUKZXZlbnR1YWlzIGRlc3Blc2FzIHF1ZSB2aWVyZW0gYSBzdXBvcnRhciwgZW0gcmF6w6NvIGRlIHF1YWxxdWVyIG9mZW5zYSBhIGRpcmVpdG9zIGF1dG9yYWlzIG91CmRpcmVpdG9zIGRlIHZveiBvdSBpbWFnZW0sIHByaW5jaXBhbG1lbnRlIG5vIHF1ZSBkaXogcmVzcGVpdG8gYSBwbMOhZ2lvIGUgdmlvbGHDp8O1ZXMgZGUgZGlyZWl0b3M7CgooNSkgQUZJUk1BIHF1ZSBjb25oZWNlIGEgUG9sw610aWNhIEluc3RpdHVjaW9uYWwgZGUgQWNlc3NvIEFiZXJ0byBkYSBGSU9DUlVaIC0gRlVOREHDh8ODTwpPU1dBTERPIENSVVogZSBhcyBkaXJldHJpemVzIHBhcmEgbyBmdW5jaW9uYW1lbnRvIGRvIHJlcG9zaXTDs3JpbyBpbnN0aXR1Y2lvbmFsIEFSQ0EuCgpBIFBvbMOtdGljYSBJbnN0aXR1Y2lvbmFsIGRlIEFjZXNzbyBBYmVydG8gZGEgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaIHJlc2VydmEKZXhjbHVzaXZhbWVudGUgYW8gQVVUT1Igb3MgZGlyZWl0b3MgbW9yYWlzIGUgb3MgdXNvcyBjb21lcmNpYWlzIHNvYnJlIGFzIG9icmFzIGRlIHN1YSBhdXRvcmlhCmUvb3UgdGl0dWxhcmlkYWRlLCBzZW5kbyBvcyB0ZXJjZWlyb3MgdXN1w6FyaW9zIHJlc3BvbnPDoXZlaXMgcGVsYSBhdHJpYnVpw6fDo28gZGUgYXV0b3JpYSBlIG1hbnV0ZW7Dp8OjbwpkYSBpbnRlZ3JpZGFkZSBkYSBPQlJBIGVtIHF1YWxxdWVyIHV0aWxpemHDp8Ojby4KCkEgUG9sw610aWNhIEluc3RpdHVjaW9uYWwgZGUgQWNlc3NvIEFiZXJ0byBkYSBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPIENSVVoKcmVzcGVpdGEgb3MgY29udHJhdG9zIGUgYWNvcmRvcyBwcmVleGlzdGVudGVzIGRvcyBBdXRvcmVzIGNvbSB0ZXJjZWlyb3MsIGNhYmVuZG8gYW9zIEF1dG9yZXMKaW5mb3JtYXIgw6AgSW5zdGl0dWnDp8OjbyBhcyBjb25kacOnw7VlcyBlIG91dHJhcyByZXN0cmnDp8O1ZXMgaW1wb3N0YXMgcG9yIGVzdGVzIGluc3RydW1lbnRvcy4KRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:33:56Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients
title Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients
spellingShingle Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients
Penna, Gerson Oliveira
Hanseníase Multibacilar
Fatores de Tempo
Diagnóstico precoce
Tuberculose resistente a drogas
Resultado do tratamento
Humanos
Brasil
Leprosy, Multibacillary
Time Factors
Early diagnosis
Drug Resistant Tuberculosis
Treatment Outcome
Humans
Brazil
title_short Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients
title_full Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients
title_fullStr Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients
title_full_unstemmed Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients
title_sort Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients
author Penna, Gerson Oliveira
author_facet Penna, Gerson Oliveira
Bührer-Sékula, Samira
Kerr, Lígia Regina Sansigolo
Stefani, Mariane Martins de Araújo
Rodrigues, Laura Cunha
Araújo, Marcelo Grossi de
Ramos, Andrea Machado Coelho
Andrade, Ana Regina Coelho de
Costa, Maurício Barcelos
Rosa, Patricia Sammarco
Gonçalves, Heitor de Sá
Cruz, Rossilene
Barreto, Maurício Lima
Pontes, Maria Araci de Andrade
Penna, Maria Lúcia Fernandes
author_role author
author2 Bührer-Sékula, Samira
Kerr, Lígia Regina Sansigolo
Stefani, Mariane Martins de Araújo
Rodrigues, Laura Cunha
Araújo, Marcelo Grossi de
Ramos, Andrea Machado Coelho
Andrade, Ana Regina Coelho de
Costa, Maurício Barcelos
Rosa, Patricia Sammarco
Gonçalves, Heitor de Sá
Cruz, Rossilene
Barreto, Maurício Lima
Pontes, Maria Araci de Andrade
Penna, Maria Lúcia Fernandes
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Penna, Gerson Oliveira
Bührer-Sékula, Samira
Kerr, Lígia Regina Sansigolo
Stefani, Mariane Martins de Araújo
Rodrigues, Laura Cunha
Araújo, Marcelo Grossi de
Ramos, Andrea Machado Coelho
Andrade, Ana Regina Coelho de
Costa, Maurício Barcelos
Rosa, Patricia Sammarco
Gonçalves, Heitor de Sá
Cruz, Rossilene
Barreto, Maurício Lima
Pontes, Maria Araci de Andrade
Penna, Maria Lúcia Fernandes
dc.subject.other.pt_BR.fl_str_mv Hanseníase Multibacilar
Fatores de Tempo
Diagnóstico precoce
Tuberculose resistente a drogas
Resultado do tratamento
Humanos
Brasil
topic Hanseníase Multibacilar
Fatores de Tempo
Diagnóstico precoce
Tuberculose resistente a drogas
Resultado do tratamento
Humanos
Brasil
Leprosy, Multibacillary
Time Factors
Early diagnosis
Drug Resistant Tuberculosis
Treatment Outcome
Humans
Brazil
dc.subject.en.pt_BR.fl_str_mv Leprosy, Multibacillary
Time Factors
Early diagnosis
Drug Resistant Tuberculosis
Treatment Outcome
Humans
Brazil
description U-MDT Leprosy clinical trial ± Brazil was funded by the Department of Science and Technology (DECIT) of Brazilian Ministry of Health and the Brazilian Council for Research (CNPq process #403293/2005-7)
publishDate 2017
dc.date.issued.fl_str_mv 2017
dc.date.accessioned.fl_str_mv 2018-03-27T17:01:58Z
dc.date.available.fl_str_mv 2018-03-27T17:01:58Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv PENNA, G. O. et al. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients. PLoS Neglected Tropical Diseases, v. 11, n. 7, p. e0005725, 2017.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/25529
dc.identifier.issn.pt_BR.fl_str_mv 1935-2727
dc.identifier.doi.none.fl_str_mv 10.1371/journal.pntd.0005725
identifier_str_mv PENNA, G. O. et al. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients. PLoS Neglected Tropical Diseases, v. 11, n. 7, p. e0005725, 2017.
1935-2727
10.1371/journal.pntd.0005725
url https://www.arca.fiocruz.br/handle/icict/25529
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Public Library of Science
publisher.none.fl_str_mv Public Library of Science
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/25529/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/25529/2/Penna%20GO%20Uniform%20multidrug%20therapy%20for%20leprosy....pdf
https://www.arca.fiocruz.br/bitstream/icict/25529/3/Penna%20GO%20Uniform%20multidrug%20therapy%20for%20leprosy....pdf.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
2a0d3c844f1146b106bd3c2c66d2fd68
3a8ca3cf84ba1bab122c82cef49374c2
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009013069053952